000 | 01820 a2200517 4500 | ||
---|---|---|---|
005 | 20250517200713.0 | ||
264 | 0 | _c20180918 | |
008 | 201809s 0 0 eng d | ||
022 | _a1873-3476 | ||
024 | 7 |
_a10.1016/j.ijpharm.2018.01.051 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aIbrahim, Shaimaa | |
245 | 0 | 0 |
_aCurcumin marinosomes as promising nano-drug delivery system for lung cancer. _h[electronic resource] |
260 |
_bInternational journal of pharmaceutics _cApr 2018 |
||
300 |
_a40-49 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aA549 Cells |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
650 | 0 | 4 |
_aAntioxidants _xadministration & dosage |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCurcumin _xadministration & dosage |
650 | 0 | 4 | _aDelayed-Action Preparations |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Compounding |
650 | 0 | 4 | _aDrug Stability |
650 | 0 | 4 | _aDrug Storage |
650 | 0 | 4 |
_aEuphausiacea _xchemistry |
650 | 0 | 4 |
_aFatty Acids, Unsaturated _xchemistry |
650 | 0 | 4 |
_aHuman Umbilical Vein Endothelial Cells _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInhibitory Concentration 50 |
650 | 0 | 4 | _aLiposomes |
650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
650 | 0 | 4 | _aNanomedicine |
650 | 0 | 4 | _aNanoparticles |
650 | 0 | 4 | _aOxidation-Reduction |
650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
650 | 0 | 4 | _aTemperature |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aTagami, Tatsuaki | |
700 | 1 | _aKishi, Toshihiro | |
700 | 1 | _aOzeki, Tetsuya | |
773 | 0 |
_tInternational journal of pharmaceutics _gvol. 540 _gno. 1-2 _gp. 40-49 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijpharm.2018.01.051 _zAvailable from publisher's website |
999 |
_c28051751 _d28051751 |